NORPACE CR

LOE Approaching

disopyramide phosphate

NDAORALCAPSULE, EXTENDED RELEASE
Approved
Jul 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100

Mechanism of Action

Mechanisms of Action Norpace (disopyramide phosphate) is a Type 1 antiarrhythmic drug (i.e., similar to procainamide and quinidine). In animal studies Norpace decreases the rate of diastolic depolarization (phase 4) in cells with augmented automaticity, decreases the upstroke velocity (phase 0) and…